Comment on ‘Lebrikizumab provides stable skin response with no or minimal fluctuations for up to 2 years in patients with atopic dermatitis’

Clinical and Experimental Dermatology · Published 2026-07-13 · DOI 10.1093/ced/llag298

Authors (3)

Ercan Yılmaz, Nezihe Koker Ozer, Erdem Topal

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Yılmaz, E., Ozer, N., Topal, E. (2026). Comment on ‘Lebrikizumab provides stable skin response with no or minimal fluctuations for up to 2 years in patients with atopic dermatitis’. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llag298

Related articles